{"id":17790,"date":"2022-09-29T10:45:04","date_gmt":"2022-09-29T09:45:04","guid":{"rendered":"http:\/\/anpp.wp\/?p=17790"},"modified":"2024-05-08T10:34:44","modified_gmt":"2024-05-08T09:34:44","slug":"renforcement-de-la-cooperation-entre-lalgerie-et-le-pnud","status":"publish","type":"post","link":"https:\/\/anpp.dz\/fr\/renforcement-de-la-cooperation-entre-lalgerie-et-le-pnud\/","title":{"rendered":"Renforcement de la coop\u00e9ration entre l\u2019Alg\u00e9rie et le PNUD"},"content":{"rendered":"\n<p><img loading=\"lazy\" decoding=\"async\" height=\"16\" width=\"16\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/t4a\/1.5\/16\/1f537.png\" alt=\"\ud83d\udd37\"><img loading=\"lazy\" decoding=\"async\" height=\"16\" width=\"16\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/tc9\/1.5\/16\/1f536.png\" alt=\"\ud83d\udd36\">Le Ministre de l\u2019Industrie Pharmaceutique Mr Ali Aoun a re\u00e7u en audience, ce jeudi 29 Septembre 2022, Mme Blerta Aliko Repr\u00e9sentante R\u00e9sidente du Programme des nations unis pour le d\u00e9veloppement (PNUD) en pr\u00e9sence du Directeur G\u00e9n\u00e9ral de l\u2019Agence Nationale des Produits Pharmaceutique et des cadres du Minist\u00e8re.<\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" height=\"16\" width=\"16\" alt=\"\ud83d\udd37\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/t4a\/1.5\/16\/1f537.png\"><img loading=\"lazy\" decoding=\"async\" height=\"16\" width=\"16\" alt=\"\ud83d\udd36\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/tc9\/1.5\/16\/1f536.png\">La rencontre qui s\u2019inscrit dans le cadre du renforcement de la coop\u00e9ration entre l\u2019Alg\u00e9rie et le PNUD a permis l\u2019\u00e9valuation et l\u2019\u00e9tude de l\u2019\u00e9tat d\u2019avancement du programme d\u2019appui au profit de l\u2019Agence Nationale des Produits Pharmaceutiques ainsi que les perspectives de son \u00e9largissement en vue de l\u2019accompagnement par l\u2019agence onusienne, \u00e0 travers le renforcement des capacit\u00e9s techniques et humaines, pour la production et le contr\u00f4le des vaccins et des autres produits innovants issus de la biotechnologie.<\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" height=\"16\" width=\"16\" alt=\"\ud83d\udd37\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/t4a\/1.5\/16\/1f537.png\"><img loading=\"lazy\" decoding=\"async\" height=\"16\" width=\"16\" alt=\"\ud83d\udd36\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/tc9\/1.5\/16\/1f536.png\">L\u2019audience a \u00e9galement permis d\u2019approfondir la r\u00e9flexion quant \u00e0 l\u2019opportunit\u00e9 pour les producteurs pharmaceutiques nationaux d\u2019int\u00e9grer les r\u00e9f\u00e9rentiels du PNUD et de contribuer aux diff\u00e9rents programmes onusiens au profit du continent Africain notamment dans le cadre de la lutte contre le Sida.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Ministre de l\u2019Industrie Pharmaceutique Mr Ali Aoun a re\u00e7u en audience, ce jeudi 29 Septembre 2022, Mme Blerta Aliko Repr\u00e9sentante R\u00e9sidente du Programme des nations unis pour le d\u00e9veloppement (PNUD) en pr\u00e9sence du Directeur G\u00e9n\u00e9ral de l\u2019Agence Nationale des Produits Pharmaceutique et des cadres du Minist\u00e8re. La rencontre qui s\u2019inscrit dans le cadre du [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":17791,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[303],"tags":[139,137],"class_list":["post-17790","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classe","tag-cooperation","tag-pnud"],"_links":{"self":[{"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/posts\/17790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/comments?post=17790"}],"version-history":[{"count":4,"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/posts\/17790\/revisions"}],"predecessor-version":[{"id":17796,"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/posts\/17790\/revisions\/17796"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/media\/17791"}],"wp:attachment":[{"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/media?parent=17790"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/categories?post=17790"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/anpp.dz\/fr\/wp-json\/wp\/v2\/tags?post=17790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}